ATF6 (NM_007348) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC214278L2V

Lenti ORF particles, ATF6 (mGFP-tagged)-Human activating transcription factor 6 (ATF6), 200ul, >10^7 TU/mL

Specifications

Product Data

• Type: Human Tagged ORF Clone Lentiviral Particle
• Tag: mGFP
• Symbol: ATF6
• Synonyms: ACHM7; ATF6A
• Mammalian Cell Selection: None
• Vector: pLenti-C-mGFP
• ACCN: NM_007348
• ORF Size: 2010 bp
• Sequence Data:
  ORF Nucleotide Sequence

  The ORF insert of this clone is exactly the same as(RC214278).
• OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
• OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

Reference Data

• RefSeq: NM_007348.2
• RefSeq Size: 2488 bp
• RefSeq ORF: 2013 bp
• Locus ID: 22926
• UniProt ID: P18850
• Cytogenetics: 1q23.3
• Domains: BRLZ
• Protein Families: Transcription Factors
• Protein Pathways: Alzheimer's disease
• MW: 74.4 kDa
• Gene Summary: This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]